Sequenom, the US company planning the commercial release of its non-invasive prenatal test for Down syndrome and other conditions has announced that the release has been delayed because of questions about the internal handling of its research data. The release had been scheduled for June 2009. Sequenom shares are reported to have dropped dramatically in value with the news.
You can follow the news through Patricia E Bauer's blog, News and Commentary on Disability Issues.
No comments:
Post a Comment